 | • レポートコード：20QY06-05530 • 出版社/出版日：QYResearch / 2020年6月3日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、136ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、抗毒血清のグローバル市場について種類別（人間、動物）、用途別（一価、多価）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・抗毒血清市場の概要 ・世界の主要地域別抗毒血清市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の抗毒血清市場規模2015-2026：種類別（人間、動物） ・世界の抗毒血清市場規模2015-2026：用途別（一価、多価） ・抗毒血清の北米市場規模2015-2020 ・抗毒血清のヨーロッパ市場規模2015-2020 ・抗毒血清の中国市場規模2015-2020 ・抗毒血清の日本市場規模2015-2020 ・抗毒血清の東南アジア市場規模2015-2020 ・抗毒血清のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Merck、Summerland Serums (AU)、Haffkine Bio Pharmaceutical、MicroPharm、CSL (AU)、SAVP、Flynn Pharma、Serum） ・抗毒血清の製造コスト分析 ・販売チャネル、流通業者、顧客 ・抗毒血清の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Antivenom Serum Market
The global Antivenom Serum market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.
Global Antivenom Serum Scope and Market Size
The global Antivenom Serum market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Antivenom Serum market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Antivenom Serum market is segmented into
Humans
Animals
Segment by Application, the Antivenom Serum market is segmented into
Monovalent
Polyvalent
The Antivenom Serum market is analysed and market size information is provided by regions (countries). Segment by Application, the Antivenom Serum market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Antivenom Serum Market Share Analysis
Antivenom Serum market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Antivenom Serum business, the date to enter into the Antivenom Serum market, Antivenom Serum product introduction, recent developments, etc.
The major vendors covered:
Merck
Summerland Serums (AU)
Haffkine Bio Pharmaceutical
MicroPharm
CSL (AU)
SAVP
Flynn Pharma
Serum
Table of Contents
1 Antivenom Serum Market Overview
1.1 Antivenom Serum Product Scope
1.2 Antivenom Serum Segment by Type
1.2.1 Global Antivenom Serum Sales by Type (2020-2026)
1.2.2 Humans
1.2.3 Animals
1.3 Antivenom Serum Segment by Application
1.3.1 Global Antivenom Serum Sales Comparison by Application (2020-2026)
1.3.2 Monovalent
1.3.3 Polyvalent
1.4 Antivenom Serum Market Estimates and Forecasts (2015-2026)
1.4.1 Global Antivenom Serum Sales Growth Rate (2015-2026)
1.4.2 Global Antivenom Serum Revenue and Growth Rate (2015-2026)
1.4.3 Global Antivenom Serum Price Trends (2015-2026)
2 Antivenom Serum Estimate and Forecast by Region
2.1 Global Antivenom Serum Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Antivenom Serum Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Antivenom Serum Sales Market Share by Region (2015-2020)
2.2.2 Global Antivenom Serum Revenue Market Share by Region (2015-2020)
2.3 Global Antivenom Serum Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Antivenom Serum Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Antivenom Serum Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Antivenom Serum Estimates and Projections (2015-2026)
2.4.2 Europe Antivenom Serum Estimates and Projections (2015-2026)
2.4.3 China Antivenom Serum Estimates and Projections (2015-2026)
2.4.4 Japan Antivenom Serum Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Antivenom Serum Estimates and Projections (2015-2026)
2.4.6 India Antivenom Serum Estimates and Projections (2015-2026)
3 Global Antivenom Serum Competition Landscape by Players
3.1 Global Top Antivenom Serum Players by Sales (2015-2020)
3.2 Global Top Antivenom Serum Players by Revenue (2015-2020)
3.3 Global Antivenom Serum Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antivenom Serum as of 2019)
3.4 Global Antivenom Serum Average Price by Company (2015-2020)
3.5 Manufacturers Antivenom Serum Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Antivenom Serum Players (Opinion Leaders)
4 Global Antivenom Serum Market Size by Type
4.1 Global Antivenom Serum Historic Market Review by Type (2015-2020)
4.1.1 Global Antivenom Serum Sales Market Share by Type (2015-2020)
4.1.2 Global Antivenom Serum Revenue Market Share by Type (2015-2020)
4.1.3 Global Antivenom Serum Price by Type (2014-2020)
4.2 Global Antivenom Serum Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Antivenom Serum Sales Forecast by Type (2021-2026)
4.2.2 Global Antivenom Serum Revenue Forecast by Type (2021-2026)
4.2.3 Global Antivenom Serum Price Forecast by Type (2021-2026)
5 Global Antivenom Serum Market Size by Application
5.1 Global Antivenom Serum Historic Market Review by Application (2015-2020)
5.1.1 Global Antivenom Serum Sales Market Share by Application (2015-2020)
5.1.2 Global Antivenom Serum Revenue Market Share by Application (2015-2020)
5.1.3 Global Antivenom Serum Price by Application (2015-2020)
5.2 Global Antivenom Serum Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Antivenom Serum Sales Forecast by Application (2021-2026)
5.2.2 Global Antivenom Serum Revenue Forecast by Application (2021-2026)
5.2.3 Global Antivenom Serum Price Forecast by Application (2021-2026)
3 North America Antivenom Serum Market Facts & Figures
3.2 North America Antivenom Serum Sales Market Share by Company (2015-2020)
3.3 North America Antivenom Serum Sales Market Share by Type (2015-2020)
3.4 North America Antivenom Serum Sales Market Share by Application (2015-2020)
4 Europe Antivenom Serum Market Facts & Figures
4.2 Europe Antivenom Serum Sales Market Share by Company (2015-2020)
4.3 Europe Antivenom Serum Sales Market Share by Type (2015-2020)
4.4 Europe Antivenom Serum Sales Market Share by Application (2015-2020)
5 China Antivenom Serum Market Facts & Figures
5.2 China Antivenom Serum Sales Market Share by Company (2015-2020)
5.3 China Antivenom Serum Sales Market Share by Type (2015-2020)
5.4 China Antivenom Serum Sales Market Share by Application (2015-2020)
6 Japan Antivenom Serum Market Facts & Figures
6.2 Japan Antivenom Serum Sales Market Share by Company (2015-2020)
6.3 Japan Antivenom Serum Sales Market Share by Type (2015-2020)
6.4 Japan Antivenom Serum Sales Market Share by Application (2015-2020)
7 Southeast Asia Antivenom Serum Market Facts & Figures
7.2 Southeast Asia Antivenom Serum Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Antivenom Serum Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Antivenom Serum Sales Market Share by Application (2015-2020)
8 India Antivenom Serum Market Facts & Figures
8.2 India Antivenom Serum Sales Market Share by Company (2015-2020)
8.3 India Antivenom Serum Sales Market Share by Type (2015-2020)
8.4 India Antivenom Serum Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Antivenom Serum Business
12.1 Merck
12.1.1 Merck Antivenom Serum Corporation Information
12.1.2 Merck Antivenom Serum Business Overview and Total Revenue
12.1.3 Merck Antivenom Serum Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Merck Antivenom Serum Products Offered
12.1.5 Merck Recent Development
12.2 Summerland Serums (AU)
12.2.1 Summerland Serums (AU) Antivenom Serum Corporation Information
12.2.2 Summerland Serums (AU) Antivenom Serum Business Overview and Total Revenue
12.2.3 Summerland Serums (AU) Antivenom Serum Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Summerland Serums (AU) Antivenom Serum Products Offered
12.2.5 Summerland Serums (AU) Recent Development
12.3 Haffkine Bio Pharmaceutical
12.3.1 Haffkine Bio Pharmaceutical Antivenom Serum Corporation Information
12.3.2 Haffkine Bio Pharmaceutical Antivenom Serum Business Overview and Total Revenue
12.3.3 Haffkine Bio Pharmaceutical Antivenom Serum Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Haffkine Bio Pharmaceutical Antivenom Serum Products Offered
12.3.5 Haffkine Bio Pharmaceutical Recent Development
12.4 MicroPharm
12.4.1 MicroPharm Antivenom Serum Corporation Information
12.4.2 MicroPharm Antivenom Serum Business Overview and Total Revenue
12.4.3 MicroPharm Antivenom Serum Sales, Revenue and Gross Margin (2015-2020)
12.4.4 MicroPharm Antivenom Serum Products Offered
12.4.5 MicroPharm Recent Development
12.5 CSL (AU)
12.5.1 CSL (AU) Antivenom Serum Corporation Information
12.5.2 CSL (AU) Antivenom Serum Business Overview and Total Revenue
12.5.3 CSL (AU) Antivenom Serum Sales, Revenue and Gross Margin (2015-2020)
12.5.4 CSL (AU) Antivenom Serum Products Offered
12.5.5 CSL (AU) Recent Development
12.6 SAVP
12.6.1 SAVP Antivenom Serum Corporation Information
12.6.2 SAVP Antivenom Serum Business Overview and Total Revenue
12.6.3 SAVP Antivenom Serum Sales, Revenue and Gross Margin (2015-2020)
12.6.4 SAVP Antivenom Serum Products Offered
12.6.5 SAVP Recent Development
12.7 Flynn Pharma
12.7.1 Flynn Pharma Antivenom Serum Corporation Information
12.7.2 Flynn Pharma Antivenom Serum Business Overview and Total Revenue
12.7.3 Flynn Pharma Antivenom Serum Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Flynn Pharma Antivenom Serum Products Offered
12.7.5 Flynn Pharma Recent Development
12.8 Serum
12.8.1 Serum Antivenom Serum Corporation Information
12.8.2 Serum Antivenom Serum Business Overview and Total Revenue
12.8.3 Serum Antivenom Serum Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Serum Antivenom Serum Products Offered
12.8.5 Serum Recent Development
13 Antivenom Serum Manufacturing Cost Analysis
13.1 Antivenom Serum Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Antivenom Serum
13.4 Antivenom Serum Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Antivenom Serum Distributors List
14.3 Antivenom Serum Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Antivenom Serum Sales (K Doses) Growth Rate by Type (2020-2026)
Table 2. Global Antivenom Serum Sales (K Doses) Comparison by Application (2020-2026)
Table 3. Global Market Antivenom Serum Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Antivenom Serum Sales (K Doses) by Region (2015-2020)
Table 5. Global Antivenom Serum Sales Market Share by Region (2015-2020)
Table 6. Global Antivenom Serum Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Antivenom Serum Revenue Share by Region (2015-2020)
Table 8. Global Antivenom Serum Sales (K Doses) Forecast by Region (2021-2026)
Table 9. Global Antivenom Serum Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Antivenom Serum Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Antivenom Serum Revenue Share Forecast by Region (2021-2026)
Table 12. Global Antivenom Serum (K Doses) of Key Companies (2015-2020)
Table 13. Global Antivenom Serum Sales Share by Company (2015-2020)
Table 14. Global Antivenom Serum Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Antivenom Serum Revenue Share by Company (2015-2020)
Table 16. Global Antivenom Serum by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antivenom Serum as of 2019)
Table 17. Global Antivenom Serum Average Price (USD/Dose) of Key Company (2015-2020)
Table 18. Manufacturers Antivenom Serum Manufacturing Sites and Area Served
Table 19. Manufacturers Antivenom Serum Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Antivenom Serum Players
Table 22. Global Antivenom Serum Sales (K Doses) by Type (2015-2020)
Table 23. Global Antivenom Serum Sales Share by Type (2015-2020)
Table 24. Global Antivenom Serum Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Antivenom Serum Price (K Doses) by Type (2015-2020)
Table 26. Global Antivenom Serum Sales Share by Type (2021-2026)
Table 27. Global Antivenom Serum Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Antivenom Serum Revenue Share by Type (2021-2026)
Table 29. Global Antivenom Serum Price (K Doses) by Type (2021-2026)
Table 30. Global Antivenom Serum Sales (K Doses) by Application (2015-2020)
Table 31. Global Antivenom Serum Sales Share by Application (2015-2020)
Table 32. Global Antivenom Serum Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Antivenom Serum Price (K Doses) by Application (2015-2020)
Table 34. Global Antivenom Serum Sales (K Doses) by Application (2021-2026)
Table 35. Global Antivenom Serum Sales Share by Application (2021-2026)
Table 36. Global Antivenom Serum Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Antivenom Serum Revenue Share by Application (2021-2026)
Table 38. Global Antivenom Serum Price (K Doses) by Application (2021-2026)
Table 39. United States Antivenom Serum Sales (K Doses) by Company (2015-2020)
Table 40. United States Antivenom Serum Sales Market Share by Company (2015-2020)
Table 41. United States Antivenom Serum Sales (K Doses) by Type (2015-2020)
Table 42. United States Antivenom Serum Sales Market Share by Type (2015-2020)
Table 43. United States Antivenom Serum Sales (K Doses) by Application (2015-2020)
Table 44. United States Antivenom Serum Sales Market Share by Application (2015-2020)
Table 45. Europe Antivenom Serum Sales (K Doses) by Company (2015-2020)
Table 46. Europe Antivenom Serum Sales Market Share by Company (2015-2020)
Table 47. Europe Antivenom Serum Sales (K Doses) by Type (2015-2020)
Table 48. Europe Antivenom Serum Sales Market Share by Type (2015-2020)
Table 49. Europe Antivenom Serum Sales (K Doses) by Application (2015-2020)
Table 50. Europe Antivenom Serum Sales Market Share by Type (2015-2020)
Table 51. China Antivenom Serum Sales (K Doses) by Company (2015-2020)
Table 52. China Antivenom Serum Sales Market Share by Company (2015-2020)
Table 53. China Antivenom Serum Sales (K Doses) by Type (2015-2020)
Table 54. China Antivenom Serum Sales Market Share by Type (2015-2020)
Table 55. China Antivenom Serum Sales (K Doses) by Application (2015-2020)
Table 56. China Antivenom Serum Sales Market Share by Application (2015-2020)
Table 57. Japan Antivenom Serum Sales (K Doses) by Company (2015-2020)
Table 58. Japan Antivenom Serum Sales Market Share by Company (2015-2020)
Table 59. Japan Antivenom Serum Sales (K Doses) by Type (2015-2020)
Table 60. Japan Antivenom Serum Sales Market Share by Type (2015-2020)
Table 61. Japan Antivenom Serum Sales (K Doses) by Application (2015-2020)
Table 62. Japan Antivenom Serum Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Antivenom Serum Sales (K Doses) by Company (2015-2020)
Table 64. Southeast Asia Antivenom Serum Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Antivenom Serum Sales (K Doses) by Type (2015-2020)
Table 66. Southeast Asia Antivenom Serum Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Antivenom Serum Sales (K Doses) by Type (2015-2020)
Table 68. Southeast Asia Antivenom Serum Sales Market Share by Application (2015-2020)
Table 69. India Antivenom Serum Sales (K Doses) by Company (2015-2020)
Table 70. India Antivenom Serum Sales Market Share by Company (2015-2020)
Table 71. India Antivenom Serum Sales (K Doses) by Type (2015-2020)
Table 72. India Antivenom Serum Sales Market Share by Type (2015-2020)
Table 73. India Antivenom Serum Sales (K Doses) by Application (2015-2020)
Table 74. India Antivenom Serum Sales Market Share by Application (2015-2020)
Table 75. Merck Corporation Information
Table 76. Merck Description and Business Overview
Table 77. Merck Antivenom Serum Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 78. Merck Antivenom Serum Product
Table 79. Merck Recent Development
Table 80. Summerland Serums (AU) Corporation Information
Table 81. Summerland Serums (AU) Description and Business Overview
Table 82. Summerland Serums (AU) Antivenom Serum Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 83. Summerland Serums (AU) Antivenom Serum Product
Table 84. Summerland Serums (AU) Recent Development
Table 85. Haffkine Bio Pharmaceutical Corporation Information
Table 86. Haffkine Bio Pharmaceutical Description and Business Overview
Table 87. Haffkine Bio Pharmaceutical Antivenom Serum Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 88. Haffkine Bio Pharmaceutical Antivenom Serum Product
Table 89. Haffkine Bio Pharmaceutical Recent Development
Table 90. MicroPharm Corporation Information
Table 91. MicroPharm Description and Business Overview
Table 92. MicroPharm Antivenom Serum Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 93. MicroPharm Antivenom Serum Product
Table 94. MicroPharm Recent Development
Table 95. CSL (AU) Corporation Information
Table 96. CSL (AU) Description and Business Overview
Table 97. CSL (AU) Antivenom Serum Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 98. CSL (AU) Antivenom Serum Product
Table 99. CSL (AU) Recent Development
Table 100. SAVP Corporation Information
Table 101. SAVP Description and Business Overview
Table 102. SAVP Antivenom Serum Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 103. SAVP Antivenom Serum Product
Table 104. SAVP Recent Development
Table 105. Flynn Pharma Corporation Information
Table 106. Flynn Pharma Description and Business Overview
Table 107. Flynn Pharma Antivenom Serum Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 108. Flynn Pharma Antivenom Serum Product
Table 109. Flynn Pharma Recent Development
Table 110. Serum Corporation Information
Table 111. Serum Antivenom Serum Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 112. Serum Description and Business Overview
Table 113. Serum Antivenom Serum Product
Table 114. Serum Recent Development
Table 115. Production Base and Market Concentration Rate of Raw Material
Table 116. Key Suppliers of Raw Materials
Table 117. Antivenom Serum Distributors List
Table 118. Antivenom Serum Customers List
Table 119. Market Key Trends
Table 120. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 121. Key Challenges
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Antivenom Serum Product Picture
Figure 2. Global Antivenom Serum Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Antivenom Serum Market Share by Application in 2020 & 2026
Figure 6. Monovalent Examples
Figure 7. Polyvalent Examples
Figure 8. Global Antivenom Serum Sales (K Doses) Growth Rate (2015-2026)
Figure 9. Global Antivenom Serum Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Antivenom Serum Price Trends Growth Rate (2015-2026) (USD/Dose)
Figure 11. Global Antivenom Serum Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Antivenom Serum Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Antivenom Serum Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Antivenom Serum Sales (K Doses) Growth Rate (2015-2026)
Figure 15. Europe Antivenom Serum Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Antivenom Serum Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Antivenom Serum Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Antivenom Serum Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Antivenom Serum Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Antivenom Serum Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Antivenom Serum Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Antivenom Serum Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Antivenom Serum Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Antivenom Serum Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Antivenom Serum Players Market Share by Revenue in Antivenom Serum 2015 & 2019
Figure 26. Antivenom Serum Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Antivenom Serum Revenue Share by Type (2015-2020)
Figure 28. Global Antivenom Serum Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Antivenom Serum Revenue Share by Application (2015-2020)
Figure 30. Global Antivenom Serum Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Antivenom Serum Sales Market Share by Type in 2019
Figure 32. United States Antivenom Serum Sales Market Share by Type in 2019
Figure 33. Europe Antivenom Serum Sales Market Share by Company in 2019
Figure 34. Europe Antivenom Serum Sales Market Share by Type in 2019
Figure 35. Europe Antivenom Serum Sales Market Share by Application in 2019
Figure 36. China Antivenom Serum Sales Market Share by Company in 2019
Figure 37. China Antivenom Serum Sales Market Share by Type in 2019
Figure 38. China Antivenom Serum Sales Market Share by Application in 2019
Figure 39. Japan Antivenom Serum Sales Market Share by Company in 2019
Figure 40. Japan Antivenom Serum Sales Market Share by Type in 2019
Figure 41. Japan Antivenom Serum Sales Market Share by Application in 2019
Figure 42. Southeast Asia Antivenom Serum Sales Market Share by Company in 2019
Figure 43. Southeast Asia Antivenom Serum Sales Market Share by Type in 2019
Figure 44. Southeast Asia Antivenom Serum Sales Market Share by Application in 2019
Figure 45. India Antivenom Serum Sales Market Share by Company in 2019
Figure 46. India Antivenom Serum Sales Market Share by Type in 2019
Figure 47. India Antivenom Serum Sales Market Share by Application in 2019
Figure 48. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Summerland Serums (AU) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Haffkine Bio Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. MicroPharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. CSL (AU) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. SAVP Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Flynn Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Serum Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Key Raw Materials Price Trend
Figure 57. Manufacturing Cost Structure of Antivenom Serum
Figure 58. Manufacturing Process Analysis of Antivenom Serum
Figure 59. Antivenom Serum Industrial Chain Analysis
Figure 60. Channels of Distribution
Figure 61. Distributors Profiles
Figure 62. Porter's Five Forces Analysis
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
抗薬物の世界市場レポート2020 Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings. They are only recommended if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depend…- ヒト血清の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Human Serum market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Human Serum market report provide…
- 胎児ウシ血清の世界市場レポート2020 Market Analysis and Insights: Global Defined Fetal Bovine Serum Market The global Defined Fetal Bovine Serum market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Defined Fetal Bovine Serum Scope and Market Siz…
- 化粧品フェイスセラムの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Cosmetics Face Serum market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Cosmetics Face Serum mar…
- ヒト血清アルブミンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Human Serum Albumin market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Human Serum Albumin marke…